Keywords: japanese, drugmakers, overseas, clinical, development, increasing, jpma

Japanese drugmakers' overseas clinical development increasing; JPMA study

Article | 15 May 2006

The number of the projects (drug candidates) under clinical development only overseas and overseas prior to domestic trials, and simultaneously ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Eisai

Sankyo

Shionogi

Go to company listing